You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

47 Results
Guidelines and Advice
Status: Current
ID: GL-C50-02
Jan 2012
Guidelines and Advice
Status: Current
ID: GL-C50-29
Mar 2012
Cancer facts
Jul 2012
Cancer facts
Mar 2012
Guidelines and Advice
Status: Current
Dec 2012
Guidelines and Advice
Status: Education and Information
Dec 2012
Drug
Other Name(s): Busulfex® , Myleran®
Quick Link(s):
Drug Monograph
Jun 2019
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Adjuvant
Drugs Used:
pemetrexed,
CISplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2019
Cancer facts
Jan 2019
Guidelines and Advice
Status: Current
ID: ES SMG-3
Jan 2019
Guidelines and Advice
Status: In-Review
ID: RR 21-5
Version: n/a
Jan 2019

Pages